Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6GDQ

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeROTATING ANODE
Source detailsRIGAKU FR-X
Temperature [K]100
Detector technologyCCD
Collection date2014-01-09
DetectorRIGAKU SATURN 944+
Wavelength(s)1.54178
Spacegroup nameP 1 21 1
Unit cell lengths48.814, 70.824, 60.334
Unit cell angles90.00, 109.59, 90.00
Refinement procedure
Resolution28.420 - 1.860
R-factor0.183
Rwork0.180
R-free0.22600
Structure solution methodFOURIER SYNTHESIS
RMSD bond length0.013
RMSD bond angle1.080
Data reduction softwareXDS
Data scaling softwareAimless
Phasing softwareBUSTER
Refinement softwareBUSTER (2.11.7)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]44.3301.910
High resolution limit [Å]1.8601.860
Rmerge0.0430.391
Number of reflections326761438
<I/σ(I)>172.2
Completeness [%]94.864.9
Redundancy3.2
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, SITTING DROP7.22930.2M (NH4)2SO4, 33.0%w/v MPEG 2000, 0.1M HEPES/NaOHpH=7.2, 0.02M Mercaptoethanol

220113

PDB entries from 2024-05-22

PDB statisticsPDBj update infoContact PDBjnumon